This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

William Ridgway, MD
Chief, Division of Rheumatology, Allergy, and Clinical Immunology and The Jack and Donald Chia Endowed Professor of Medicine at University of California, Davis, School of Medicine

Profile

William M. Ridgway, M.D., is the Jack and Donald Chia Endowed Professor of Medicine (tenured), and Chief, Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, Medical Center. He was previously the Alice W. and Mark A. Brown Professor in Internal Medicine and Director, Division of Immunology, Allergy and Rheumatology at University of Cincinnati College of Medicine from 2008-2019.  He is board-certified in Rheumatology by the American Board of Internal Medicine.  He is a fellow of the American College of Physicians and the American College of Rheumatology.  He earned his medical degree from the University of Rochester and did his residency, clinical fellowship, and postdoctoral physician and research fellowships at Stanford University Hospital and School of Medicine. He was a tenured faculty member at University of Pittsburgh School of Medicine in the division of Rheumatology, with a secondary appointment in the Department of Immunology, before moving to Cincinnati in 2008.  

Dr. Ridgway has published numerous articles in the areas of autoimmunity, immunology, Type 1 diabetes, and autoimmune biliary disease.  Dr. Ridgway lectures frequently at the medical school and graduate school level, is a rheumatology fellow preceptor for UC’s arthritis clinic, and a rheumatology consult attending. He has spoken on his research at many national meetings and is a reviewer for the NIH and multiple immunology journals.

Dr. Ridgway has done immunology research for 30 years starting in C.Garrison Fathman’s lab at Stanford University School of Medicine. He currently operates an immunology research lab investigating the immunogenetic control of autoimmunity with special emphasis on Type one diabetes, Primary Biliary Cirrhosis, T cells, and T regulatory cells. 

Agenda Sessions

  • Mechanisms of Reversal of Acute Type 1 Diabetes with a TLR-4/MD-2 Monoclonal Antibody

    3:15pm